<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Anesthesia for the patient with preeclampsia</title><link href="/z/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/z/d/css/icofont.min.css" rel="stylesheet"/><link href="/z/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/z/d/css/animate.css" rel="stylesheet"/><link href="/z/d/css/owl.carousel.css" rel="stylesheet"/><link href="/z/d/css/magnific-popup.css" rel="stylesheet"/><link href="/z/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/z/d/css/style.css" rel="stylesheet"/><link href="/z/d/css/rtl_edited.css" rel="stylesheet"/><link href="/z/d/css/responsive.css" rel="stylesheet"/><link href="https:///uptodate_assets/main.css" rel="stylesheet"/>
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>
<meta content="" name="description"/>
<link href="/z/d/img/favicon.png" rel="icon" type="image/png">
</link></head>
<body>
<!-- Start Main Menu Area -->
<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>
<section class="teacher-area ptb-10">
<div class="container">
</div>
<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Anesthesia for the patient with preeclampsia</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Anesthesia for the patient with preeclampsia</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Authors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Joy Hawkins, MD</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Emily McQuaid-Hanson, MD</a></dd><dt><span> </span>Section Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">David L Hepner, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Marianna Crowley, MD</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Jan 10, 2024.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H4260697041"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Preeclampsia is a multisystem disorder with unique concerns for the anesthesiologist in the peripartum period. This topic will discuss the anesthetic management of labor and delivery for preeclamptic patients, including labor analgesia, cesarean delivery, fluid management, and invasive monitoring. The pathogenesis, clinical features and diagnosis, and obstetric management of patients with preeclampsia are discussed separately. (See  <a class="medical medical_review" href="/z/d/html/6814.html" rel="external">"Preeclampsia: Clinical features and diagnosis"</a> and  <a class="medical medical_review" href="/z/d/html/6825.html" rel="external">"Preeclampsia: Antepartum management and timing of delivery"</a> and  <a class="medical medical_review" href="/z/d/html/6760.html" rel="external">"Preeclampsia: Pathogenesis"</a>.)</p><p class="headingAnchor" id="H4252746037"><span class="h1">PREANESTHESIA EVALUATION</span><span class="headingEndMark"> — </span>Preeclamptic patients should be evaluated by an anesthesia clinician early in labor, with the expectation that an emergency delivery may be required at any time. Patients with preeclampsia are at an increased risk for life-threatening events, including placental abruption, cerebral hemorrhage, pulmonary edema, acute kidney injury, hepatic failure or rupture, disseminated intravascular coagulation, and progression to eclampsia. (See  <a class="medical medical_review" href="/z/d/html/6814.html" rel="external">"Preeclampsia: Clinical features and diagnosis"</a>.)</p><p>The preanesthesia evaluation of these patients should focus on severity of disease, the airway examination, hemodynamic status, and coagulation parameters, all of which may change over time.</p><p class="headingAnchor" id="H3896218020"><span class="h2">Severity of preeclampsia</span><span class="headingEndMark"> — </span>Preeclampsia may be classified as severe (also called preeclampsia with severe features) or preeclampsia without severe features  (<a class="graphic graphic_table graphicRef76975" href="/z/d/graphic/76975.html" rel="external">table 1</a>). (See  <a class="medical medical_review" href="/z/d/html/6825.html" rel="external">"Preeclampsia: Antepartum management and timing of delivery"</a>.)</p><p>In general, peripartum anesthesia for patients with preeclampsia without severe features is managed as it would be for patients without preeclampsia, recognizing that severity may increase at any time. Patients with preeclampsia without severe features may or may not receive magnesium for seizure prophylaxis. (See <a class="local">'Intraoperative magnesium'</a> below and  <a class="medical medical_review" href="/z/d/html/139247.html" rel="external">"Preeclampsia: Intrapartum and postpartum management and long-term prognosis", section on 'Seizure prophylaxis'</a>.)</p><p class="headingAnchor" id="H4014850864"><span class="h2">Airway evaluation</span><span class="headingEndMark"> — </span>Airway management may be particularly difficult in preeclamptic patients who are prone to edema and bleeding with airway instrumentation. Airway edema may worsen over the course of labor, and may be present even with a reassuring airway examination. Airway evaluation is discussed separately. (See  <a class="medical medical_review" href="/z/d/html/16690.html" rel="external">"Airway management for the pregnant patient"</a> and  <a class="medical medical_review" href="/z/d/html/90615.html" rel="external">"Management of the difficult airway for general anesthesia in adults"</a>.)</p><p>Equipment necessary for difficult and emergency airway management should be available on the labor floor; urgent or emergency airway intervention may be required not only for general anesthesia for cesarean delivery, but also for airway protection if eclamptic seizures occur, or in the setting of magnesium toxicity or overdose. (See  <a class="medical medical_review" href="/z/d/html/16690.html" rel="external">"Airway management for the pregnant patient", section on 'Equipment preparation'</a>.)</p><p class="headingAnchor" id="H2317594617"><span class="h2">Hemodynamic status</span><span class="headingEndMark"> — </span>Hypertension is generally the earliest clinical finding in preeclampsia, and may be treated in the peripartum period with oral and/or intravenous vasodilators (eg, <a class="drug drug_general" data-topicid="9700" href="/z/d/drug information/9700.html" rel="external">nifedipine</a>, <a class="drug drug_general" data-topicid="9540" href="/z/d/drug information/9540.html" rel="external">labetalol</a>, <a class="drug drug_general" data-topicid="8528" href="/z/d/drug information/8528.html" rel="external">hydralazine</a>), which may affect the choice of vasoactive drugs administered during analgesia and anesthesia. (See  <a class="medical medical_review" href="/z/d/html/6815.html" rel="external">"Treatment of hypertension in pregnant and postpartum patients", section on 'Acute therapy of severe hypertension'</a>.)</p><p>With severe preeclampsia, patients may develop cardiac dysfunction, myocardial damage, and pulmonary edema, which may affect the choice and dose of anesthetic medications, and the need for invasive monitoring. (See  <a class="medical medical_review" href="/z/d/html/6814.html" rel="external">"Preeclampsia: Clinical features and diagnosis", section on 'Pulmonary edema'</a>.)</p><p class="headingAnchor" id="H2362692095"><span class="h2">Coagulation</span><span class="headingEndMark"> — </span>Patients with severe preeclampsia and/or HELLP syndrome (Hemolysis, Elevated Liver enzymes, Low Platelet count) may develop thrombocytopenia, which increases the risk of spinal epidural hematoma with neuraxial anesthesia techniques. Both the absolute platelet count, and the trend in the count over time are important considerations for the timing and advisability of neuraxial procedures. The platelet count necessary to safely perform neuraxial anesthesia is unknown [<a href="#rid1">1</a>], and practice varies. In the absence of other coagulation abnormalities, neuraxial anesthesia procedures are generally safe for patients with a platelet count ≥70,000/microL, with close follow-up for signs of spinal epidural hematoma  (<a class="graphic graphic_algorithm graphicRef131451" href="/z/d/graphic/131451.html" rel="external">algorithm 1</a>) [<a href="#rid2">2,3</a>]. We generally avoid neuraxial procedures in patients with a platelet count &lt;50,000/microL, in whom the risk of spinal epidural hematoma is likely elevated. For patients with a platelet count between 50,000 and 70,000/microL, we make an individualized decision based on the clinical scenario and risk factors [<a href="#rid3">3</a>]. (See  <a class="medical medical_review" href="/z/d/html/4469.html" rel="external">"Adverse effects of neuraxial analgesia and anesthesia for obstetrics", section on 'Neuraxial analgesia and low platelets'</a>.)</p><p>Use of low dose <a class="drug drug_general" data-topicid="8907" href="/z/d/drug information/8907.html" rel="external">aspirin</a> should not affect the decision to use neuraxial techniques. This is of interest because the United States Preventive Services Task Force [<a href="#rid4">4</a>] and the American College of Obstetricians and Gynecologists [<a href="#rid5">5</a>] recommend use of low-dose aspirin for prevention of preeclampsia in patients deemed high-risk. Risk factors for preeclampsia and the use of aspirin for prophylaxis are discussed in detail separately. (See  <a class="medical medical_review" href="/z/d/html/6817.html" rel="external">"Preeclampsia: Prevention", section on 'Low-dose aspirin'</a>.)</p><p>Other coagulopathies may develop, including disseminated intravascular coagulation, as well as liver function abnormalities, and may also preclude the use of neuraxial techniques. Coagulation testing, other than a platelet count, should be individualized based on patient factors (eg, liver function test abnormalities, abruption). Changes in prothrombin time (PT), partial thromboplastin time (PTT) and fibrinogen do not occur in most preeclamptic patients with a normal platelet count [<a href="#rid6">6,7</a>].</p><p>We do not transfuse patients with platelets solely to allow neuraxial anesthesia. However, if the obstetrician administers platelet transfusion prior to cesarean delivery, there may be an opportunity for neuraxial anesthesia. Indications for platelet transfusion and correction of coagulopathy are discussed separately. (See  <a class="medical medical_review" href="/z/d/html/139247.html" rel="external">"Preeclampsia: Intrapartum and postpartum management and long-term prognosis", section on 'Management of thrombocytopenia'</a>.)</p><p class="headingAnchor" id="H1727028980"><span class="h1">CARE SETTING: ICU VERSUS LABOR FLOOR</span><span class="headingEndMark"> — </span>Patients with preeclampsia may require invasive monitoring and intensive care during the peripartum period. The decision to care for these patients on the labor floor, or in the intensive care unit (ICU), should be institution specific, collaborative between anesthesia, obstetric, and nursing teams, and based on available resources and clinical expertise.</p><p>Advantages of care on the labor floor include:</p><p class="bulletIndent1"><span class="glyph">●</span>Proximity of the obstetric, neonatal, and obstetric anesthesia teams, for rapid response to changing clinical situations</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Familiarity of the nursing staff with intrapartum assessment of labor, fetal monitoring, and the drugs, procedures, and interventions frequently used during labor and delivery</p><p></p><p>Advantages of the intensive care unit for these patients include:</p><p class="bulletIndent1"><span class="glyph">●</span>Familiarity with invasive monitoring and vasoactive infusions</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Superior resources for maternal resuscitation</p><p></p><p>In some institutions, the best compromise may be to cross cover, with obstetric and ICU nurses sharing patient care in the most appropriate unit.</p><p class="headingAnchor" id="H818074266"><span class="h1">HEMODYNAMIC MONITORING</span><span class="headingEndMark"> — </span>Blood pressure may be labile, and change rapidly in patients with preeclampsia, due to disease progression, administration of vasoactive medications, the pain of labor, or anesthetic interventions. Invasive hemodynamic monitoring (ie, arterial catheterization, central venous catheter placement) is not routine for these patients, but may be indicated in some circumstances.</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Arterial catheterization </strong>–<strong> </strong>A radial artery catheter should be considered prior to induction of general anesthesia for patients with severe preeclampsia based on blood pressure, if time permits, to provide continuous blood pressure monitoring and rapid response to adverse changes, especially during rapid sequence induction and during emergence. (See <a class="local">'General anesthesia'</a> below and <a class="local">'Goal blood pressure'</a> below.)</p><p></p><p class="bulletIndent1">Radial artery catheters are not routinely placed for hemodynamic monitoring during labor for patients with preeclampsia. However, radial artery catheterization is a low-risk procedure [<a href="#rid8">8</a>] that may be beneficial for continuous blood pressure monitoring, and facilitates blood sampling [<a href="#rid9">9</a>]. Placement of an arterial line should be considered in the following situations:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Persistent, severe hypertension (eg, systolic blood pressure &gt;160 or diastolic blood pressure &gt;110) refractory to treatment [<a href="#rid9">9-11</a>]</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Use of vasoactive infusions to control blood pressure</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Need for frequent blood sampling (eg, patients with coagulopathy, hemorrhage, severe renal or hepatic dysfunction), particularly for patients with difficult peripheral venous access</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Need for frequent arterial blood gas monitoring (eg, patients with pulmonary edema and hypoxia)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>For use of a minimally invasive cardiac output monitor to guide hemodynamic management [<a href="#rid12">12</a>] (see  <a class="medical medical_review" href="/z/d/html/14942.html" rel="external">"Intraoperative fluid management", section on 'Dynamic parameters to assess volume responsiveness'</a>)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Central venous catheterization </strong>– Central venous catheters (CVCs) and pulmonary artery catheters (PACs) are rarely used in parturients with preeclampsia. Indications for placement are similar to those for patients without preeclampsia, including difficult peripheral venous access, central administration of vasoactive infusions, and measurement of cardiac function and/or preload. (See  <a class="medical medical_review" href="/z/d/html/100067.html" rel="external">"Basic patient monitoring during anesthesia", section on 'Other monitors of circulation'</a>.)</p><p></p><p class="bulletIndent1">However, complication rates for central line placement are relatively high in patients with severe preeclampsia [<a href="#rid13">13,14</a>], and there are no randomized trials to support the use of CVCs [<a href="#rid15">15</a>]. Placement of a CVC or PAC takes time, and should not delay delivery for patients with severe preeclampsia.</p><p></p><p class="bulletIndent1">Central venous pressure correlates poorly with pulmonary capillary wedge pressure in patients with preeclampsia [<a href="#rid16">16-18</a>]. Therefore, a PAC should be placed if measurement of preload is the primary objective.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Transthoracic echocardiography </strong>–<strong> </strong>Transthoracic echocardiography (TTE) is safe in pregnancy [<a href="#rid19">19</a>] and may be useful in assessing cardiac function in the setting of hypertension, hemodynamic instability, or respiratory failure [<a href="#rid20">20</a>]. TTE may also be used to assess volume status and guide therapeutic management in obstetric patients with preeclampsia [<a href="#rid21">21</a>]. TTE requires specialized training and frequent use to maintain competency.</p><p></p><p class="headingAnchor" id="H2324694342"><span class="h1">GOAL BLOOD PRESSURE</span><span class="headingEndMark"> — </span>For preeclamptic patients, we aim to keep the patient's blood pressure close to her baseline, rather than normal blood pressures, to preserve uteroplacental perfusion, but always less than systolic 160 mmHg and diastolic 110 mmHg. Blood pressures &gt;160/110 mmHg should be lowered aggressively, while monitoring the fetus to be sure that uteroplacental perfusion is maintained and late decelerations do not develop. The medications and doses used for treatment of acute, severe hypertension are shown in a table  (<a class="graphic graphic_table graphicRef110261" href="/z/d/graphic/110261.html" rel="external">table 2</a>).</p><p>Though specific blood pressure targets are not supported by data, goals for blood pressure management for preeclamptic patients should include:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Avoidance of severe hypertension to reduce the risk of stroke and intracranial hemorrhage</strong> – Severe systolic hypertension is associated with stroke in these patients in the peripartum period [<a href="#rid11">11</a>]. A review of 28 patients with stroke associated with severe preeclampsia found that 100 percent of the patients had systolic blood pressure (BP) greater than 155 mmHg before the stroke [<a href="#rid9">9</a>]. Ninety-three percent of the strokes were hemorrhagic events, 54 percent of the patients died, and all but three of those who survived suffered permanent disability.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Avoidance of hypotension to maintain uteroplacental perfusion </strong>–<strong> </strong>Uteroplacental perfusion may be compromised in patients with preeclampsia, and may increase the risk of fetal compromise with hypotension. (See  <a class="medical medical_review" href="/z/d/html/6814.html" rel="external">"Preeclampsia: Clinical features and diagnosis", section on 'Pathogenesis'</a>.)</p><p></p><p class="headingAnchor" id="H750856792"><span class="h1">INTRAVENOUS FLUID MANAGEMENT</span><span class="headingEndMark"> — </span>Peripartum fluid administration should be monitored closely, since patients with severe preeclampsia are at risk for pulmonary edema. The etiology of pulmonary edema in these patients may be multifactorial, including myocardial dysfunction as a result of acutely increased systemic vascular resistance, low colloid oncotic pressure with capillary leak, and iatrogenic fluid administration. (See  <a class="medical medical_review" href="/z/d/html/6814.html" rel="external">"Preeclampsia: Clinical features and diagnosis", section on 'Pulmonary edema'</a> and  <a class="medical medical_review" href="/z/d/html/139247.html" rel="external">"Preeclampsia: Intrapartum and postpartum management and long-term prognosis", section on 'Fluids'</a>.)</p><p>Current obstetric practice is to limit total fluid administration in patients with severe preeclampsia to 80 to 100 mL/hour intravenous (IV), including <a class="drug drug_general" data-topicid="9734" href="/z/d/drug information/9734.html" rel="external">oxytocin</a> and magnesium infusions. Restrictive volumes of fluid should also be administered during initiation of neuraxial labor analgesia or neuraxial anesthesia, and during anesthesia for cesarean delivery. (See <a class="local">'Fluid administration'</a> below.)</p><p>In most patients who receive low dose local anesthetic with opioid solutions for neuraxial labor analgesia (eg, 0.0625 to 0.125% <a class="drug drug_general" data-topicid="9169" href="/z/d/drug information/9169.html" rel="external">bupivacaine</a> with <a class="drug drug_general" data-topicid="8441" href="/z/d/drug information/8441.html" rel="external">fentanyl</a>), no IV bolus is required or advised to prevent hypotension [<a href="#rid22">22-24</a>]. (See  <a class="medical medical_review" href="/z/d/html/101803.html" rel="external">"Neuraxial analgesia for labor and delivery (including instrumental delivery)", section on 'Goals for neuraxial drug choice'</a> and  <a class="medical medical_review" href="/z/d/html/4469.html" rel="external">"Adverse effects of neuraxial analgesia and anesthesia for obstetrics", section on 'Hypotension'</a>.)</p><p>The limited available data do not indicate an absolute maternal or fetal benefit of colloids over crystalloids for obstetric patients in general [<a href="#rid25">25,26</a>], or for preeclamptic patients in particular [<a href="#rid27">27-29</a>].</p><p class="headingAnchor" id="H2073240343"><span class="h1">LABOR ANALGESIA</span><span class="headingEndMark"> — </span>In the absence of other contraindications, neuraxial analgesia is the preferred form of labor analgesia for patients with preeclampsia [<a href="#rid30">30</a>].</p><p>For patients in whom neuraxial analgesia is contraindicated (eg, severe coagulopathy), other options include systemic analgesics and <a class="drug drug_general" data-topicid="10086" href="/z/d/drug information/10086.html" rel="external">nitrous oxide</a>. (See  <a class="medical medical_review" href="/z/d/html/4468.html" rel="external">"Pharmacologic management of pain during labor and delivery", section on 'Opioid analgesia'</a> and  <a class="medical medical_review" href="/z/d/html/4468.html" rel="external">"Pharmacologic management of pain during labor and delivery", section on 'Nitrous oxide'</a>.)</p><p class="headingAnchor" id="H3587243778"><span class="h2">Advantages of neuraxial labor analgesia</span><span class="headingEndMark"> — </span>Some advantages of neuraxial labor analgesia are particularly relevant for patients with preeclampsia.</p><p class="bulletIndent1"><span class="glyph">●</span>Superior pain relief, compared with systemic analgesics [<a href="#rid31">31</a>]</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Attenuation of the hypertensive response to labor pain</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Reduction of circulating catecholamines [<a href="#rid32">32</a>]</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Possible improvement in placental blood flow [<a href="#rid33">33-35</a>]</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Provision of a means for rapid conversion to surgical neuraxial anesthesia, with avoidance of general anesthesia</p><p></p><p class="headingAnchor" id="H3556101543"><span class="h2">Neuraxial analgesia versus systemic opioids</span><span class="headingEndMark"> — </span>For patients <strong>without preeclampsia</strong>, the effects of neuraxial labor analgesia on the progress and outcome of labor, and on maternal and fetal outcomes, have been studied extensively. (See  <a class="medical medical_review" href="/z/d/html/4469.html" rel="external">"Adverse effects of neuraxial analgesia and anesthesia for obstetrics", section on 'Effects on the progress and outcome of labor'</a>.)</p><p>Several randomized trials have reported no difference in the mode of delivery or neonatal outcomes for patients <strong>with preeclampsia</strong> who received epidural labor analgesia, compared with systemic analgesia.</p><p class="bulletIndent1"><span class="glyph">●</span>In one study, 200 preeclamptic parturients were randomly assigned to epidural analgesia (0.125% <a class="drug drug_general" data-topicid="9169" href="/z/d/drug information/9169.html" rel="external">bupivacaine</a> with <a class="drug drug_general" data-topicid="10010" href="/z/d/drug information/10010.html" rel="external">tramadol</a>, administered by intermittent bolus) or intramuscular tramadol for labor analgesia [<a href="#rid36">36</a>]. There were no differences in hypotension, cesarean delivery rates, or neonatal apgar scores.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>In another study, 116 parturients with severe preeclampsia were randomly assigned to epidural analgesia (bolus of 0.25% <a class="drug drug_general" data-topicid="9169" href="/z/d/drug information/9169.html" rel="external">bupivacaine</a>, followed by infusion of 0.125% bupivacaine with <a class="drug drug_general" data-topicid="8441" href="/z/d/drug information/8441.html" rel="external">fentanyl</a>) or intravenous (IV) <a class="drug drug_general" data-topicid="9608" href="/z/d/drug information/9608.html" rel="external">meperidine</a> [<a href="#rid37">37</a>]. There were no differences in the cesarean delivery rate or neonatal outcomes. Infants of patients who received meperidine were more likely to require <a class="drug drug_general" data-topicid="9678" href="/z/d/drug information/9678.html" rel="external">naloxone</a>, and parturients who received epidural analgesia were more likely to require <a class="drug drug_general" data-topicid="9114" href="/z/d/drug information/9114.html" rel="external">ephedrine</a> for hypotension.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>In one small study, 30 preeclamptic patients were randomly assigned to epidural analgesia (bolus of 0.25% <a class="drug drug_general" data-topicid="9169" href="/z/d/drug information/9169.html" rel="external">bupivacaine</a>, followed by infusion of 0.125% bupivacaine with <a class="drug drug_general" data-topicid="8441" href="/z/d/drug information/8441.html" rel="external">fentanyl</a>) or <a class="drug drug_general" data-topicid="9854" href="/z/d/drug information/9854.html" rel="external">remifentanil</a> patient controlled intravenous analgesia [<a href="#rid38">38</a>]. There were no differences in maternal vital signs, neonatal outcomes, or mode of delivery.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>In a single center trial, 738 parturients with pregnancy-induced hypertension (diastolic blood pressure ≥90 mmHg, with or without other features of preeclampsia) were randomly assigned to epidural analgesia (bolus of 0.25% <a class="drug drug_general" data-topicid="9169" href="/z/d/drug information/9169.html" rel="external">bupivacaine</a> followed by infusion of 0.125% bupivacaine with <a class="drug drug_general" data-topicid="8441" href="/z/d/drug information/8441.html" rel="external">fentanyl</a>) or intravenous <a class="drug drug_general" data-topicid="9608" href="/z/d/drug information/9608.html" rel="external">meperidine</a> for labor analgesia [<a href="#rid39">39</a>]. Epidural analgesia was associated with an increase in forceps delivery (14 versus 7 percent) but no difference in the cesarean delivery rate or in neonatal outcomes.</p><p></p><p class="headingAnchor" id="H1898399458"><span class="h2">Management of neuraxial labor analgesia</span><span class="headingEndMark"> — </span>Techniques for neuraxial labor analgesia for preeclamptic patients are the same as for patients without preeclampsia, and are discussed separately. Differences in management for preeclamptic parturients are discussed here. (See  <a class="medical medical_review" href="/z/d/html/101803.html" rel="external">"Neuraxial analgesia for labor and delivery (including instrumental delivery)"</a>.)</p><p class="headingAnchor" id="H2661108003"><span class="h3">Timing of neuraxial analgesia</span><span class="headingEndMark"> — </span>We place an epidural catheter early in labor for patients with preeclampsia. Early placement is especially important for patients with declining platelet counts before severe thrombocytopenia occurs, and for patients with expected difficulty with airway management. (See <a class="local">'Advantages of neuraxial labor analgesia'</a> above.)</p><p class="headingAnchor" id="H2017261243"><span class="h3">The epidural test dose</span><span class="headingEndMark"> — </span>The administration of a test dose with <a class="drug drug_general" data-topicid="9409" href="/z/d/drug information/9409.html" rel="external">epinephrine</a> after epidural catheter placement in obstetrics is controversial, and practice varies. (See  <a class="medical medical_review" href="/z/d/html/101803.html" rel="external">"Neuraxial analgesia for labor and delivery (including instrumental delivery)", section on 'The epidural test dose in obstetrics'</a>.)</p><p>For preeclamptic patients, alternative test dose solutions, without <a class="drug drug_general" data-topicid="9409" href="/z/d/drug information/9409.html" rel="external">epinephrine</a>, may be used (eg, <a class="drug drug_general" data-topicid="8441" href="/z/d/drug information/8441.html" rel="external">fentanyl</a>, or air) (see  <a class="medical medical_review" href="/z/d/html/101803.html" rel="external">"Neuraxial analgesia for labor and delivery (including instrumental delivery)", section on 'The epidural test dose in obstetrics'</a>), since epinephrine test doses may be unreliable (eg, for patients who have received beta blockers), or may cause severe hypertension if inadvertent intravascular injection occurs. One author avoids an epinephrine test dose for preeclamptic patients, and tests the epidural catheter by administering a dilute epidural solution of local anesthetic and opioid, assessing for the onset of appropriate block. The other author administers an epinephrine containing test dose (eg, 3 cc of <a class="drug drug_general" data-topicid="9558" href="/z/d/drug information/9558.html" rel="external">lidocaine</a> 1.5% with epinephrine 1:200,000). If 15 mcg epinephrine is used for a test dose in a patient with severe preeclampsia, the provider must be prepared to treat severe hypertension emergently in the event of an intravascular injection or even rapid absorption.</p><p class="headingAnchor" id="H404880199"><span class="h3">Vasopressors during neuraxial analgesia</span><span class="headingEndMark"> — </span>Blood pressure may be labile during labor, and after administration of labor analgesia. Vasodilators, vasopressors, and beta blockers are commonly required in preeclamptic patients. (See <a class="local">'Hemodynamic status'</a> above and  <a class="medical medical_review" href="/z/d/html/6815.html" rel="external">"Treatment of hypertension in pregnant and postpartum patients", section on 'Choice of therapy'</a>.)</p><p>When needed, vasopressors (eg, <a class="drug drug_general" data-topicid="9114" href="/z/d/drug information/9114.html" rel="external">ephedrine</a>, <a class="drug drug_general" data-topicid="9768" href="/z/d/drug information/9768.html" rel="external">phenylephrine</a>) should be administered in small doses (eg, ephedrine 2.5 to 5 mg IV, phenylephrine 25 to 50 mcg IV) to preeclamptic patients, and titrated to effect, as their responses to these medications may be unpredictable. Preeclamptic patients are more sensitive to various vasopressors, including <a class="drug drug_general" data-topicid="9709" href="/z/d/drug information/9709.html" rel="external">norepinephrine</a> [<a href="#rid40">40</a>] and <a class="drug drug_general" data-topicid="9409" href="/z/d/drug information/9409.html" rel="external">epinephrine</a> [<a href="#rid41">41</a>] and require lower doses of ephedrine and phenylephrine to reverse spinal hypotension [<a href="#rid42">42-44</a>].</p><p class="headingAnchor" id="H110557569"><span class="h3">Epidural catheter removal</span><span class="headingEndMark"> — </span>Removal of the epidural catheter may cause epidural blood vessel injury that could lead to spinal epidural hematoma. The catheter should not be removed unless the platelet count and coagulation studies are at a level that would allow neuraxial needle insertion. (See <a class="local">'Coagulation'</a> above.)</p><p class="headingAnchor" id="H2996599625"><span class="h1">ANESTHESIA FOR CESAREAN DELIVERY</span><span class="headingEndMark"> — </span>Cesarean delivery (CD) may be performed with neuraxial anesthesia (ie, spinal, combined spinal-epidural [CSE], or epidural) or general anesthesia.</p><p class="headingAnchor" id="H2276505926"><span class="h2">Intravenous access</span><span class="headingEndMark"> — </span>We place two intravenous (IV) catheters, including at least one large bore catheter (ie, 18 gauge or larger), to facilitate administration of magnesium, vasoactive infusions, <a class="drug drug_general" data-topicid="9734" href="/z/d/drug information/9734.html" rel="external">oxytocin</a>, IV fluid, and blood products as well as our anesthetic medications.</p><p class="headingAnchor" id="H785231152"><span class="h2">Choice of anesthetic technique</span></p><p class="headingAnchor" id="H2196027175"><span class="h3">General versus neuraxial anesthesia</span><span class="headingEndMark"> — </span>Neuraxial anesthesia is preferred for preeclamptic patients who undergo CD, rather than general anesthesia, whenever possible. The most important advantage to neuraxial anesthesia is that it avoids the severe hypertension, which may be life threatening, that may occur during induction of and emergence from anesthesia. (See <a class="local">'Goal blood pressure'</a> above.)</p><p>In addition to the advantages of neuraxial anesthesia for CD in non-preeclamptic patients, considerations for patients with preeclampsia include the following:</p><p class="bulletIndent1"><span class="glyph">●</span>Neuraxial anesthesia avoids the need for endotracheal intubation, which may be difficult in these edematous patients.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Neuraxial anesthesia avoids the need for administration of neuromuscular blocking agents, which are potentiated by magnesium. (See <a class="local">'Intraoperative magnesium'</a> below.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Neuraxial anesthesia may cause more hypotension than general anesthesia, but it is usually transient and easily treated, without a difference in neonatal outcome [<a href="#rid45">45,46</a>].</p><p></p><p class="headingAnchor" id="H673845743"><span class="h3">Choice of neuraxial technique</span><span class="headingEndMark"> — </span>The choice of neuraxial anesthetic technique (ie, spinal, epidural, or CSE) should be based on patient factors and the clinical context. Spinal and CSE are often used when a labor epidural catheter has not been in place.</p><p>Historically, spinal anesthesia was avoided in patients with severe preeclampsia because of the possibility of profound hypotension related to the rapid onset of sympathetic block. (See  <a class="medical medical_review" href="/z/d/html/4469.html" rel="external">"Adverse effects of neuraxial analgesia and anesthesia for obstetrics", section on 'Hypotension'</a>.)</p><p>A number of studies have refuted these concerns, including the following:</p><p class="bulletIndent1"><span class="glyph">●</span>In one trial, 80 patients with severe preeclampsia were randomly assigned to general, epidural, or CSE for CD [<a href="#rid46">46</a>]. There were no differences in mean highest or lowest blood pressures, or neonatal outcomes, with any of the anesthetic techniques.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>In another trial, 100 severely preeclamptic patients were randomly assigned to epidural or spinal anesthesia for CD [<a href="#rid47">47</a>]. Hypotension was more common in the spinal group (51 versus 23 percent). However, the duration of significant hypotension (systolic blood pressure [BP] ≤100) was brief (≤1 minute) in both groups and was easily treated with small doses of <a class="drug drug_general" data-topicid="9114" href="/z/d/drug information/9114.html" rel="external">ephedrine</a>.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>A retrospective review of 140 severely preeclamptic patients who underwent CD reported no difference in lowest blood pressures between spinal and epidural anesthesia, with no difference in maternal or fetal outcomes [<a href="#rid48">48</a>].</p><p></p><p>Patients with preeclampsia may be at lower risk for spinal induced hypotension than patients without preeclampsia. Two prospective case controlled studies of severely preeclamptic patients who underwent cesarean delivery at term [<a href="#rid43">43</a>] and preterm [<a href="#rid42">42</a>] reported lower incidences of spinal hypotension and <a class="drug drug_general" data-topicid="9114" href="/z/d/drug information/9114.html" rel="external">ephedrine</a> requirement in the preeclamptic patients.</p><p class="headingAnchor" id="H620894300"><span class="h2">Anesthetic management of neuraxial anesthesia</span><span class="headingEndMark"> — </span>The techniques and doses of neuraxial medications for preeclamptic patients are similar to those for parturients without preeclampsia, and are discussed separately. (See  <a class="medical medical_review" href="/z/d/html/4480.html" rel="external">"Anesthesia for cesarean delivery", section on 'Neuraxial anesthesia'</a>.)</p><p>Concerns specific to preeclamptic patients are discussed here.</p><p class="headingAnchor" id="H4019871092"><span class="h3">Fluid administration</span><span class="headingEndMark"> — </span>IV fluid co-loading during placement of neuraxial anesthesia should be avoided or minimized (ie, &lt;500 mL crystalloid solution IV) for patients with severe preeclampsia. Intraoperative fluid administration should be conservative as well. (See <a class="local">'Intravenous fluid management'</a> above.)</p><p class="headingAnchor" id="H3794460705"><span class="h3">Vasopressors during cesarean delivery</span><span class="headingEndMark"> — </span>Vasopressors (eg, <a class="drug drug_general" data-topicid="9768" href="/z/d/drug information/9768.html" rel="external">phenylephrine</a> and/or <a class="drug drug_general" data-topicid="9114" href="/z/d/drug information/9114.html" rel="external">ephedrine</a>) are routinely administered during initiation of spinal anesthesia to prevent spinal hypotension. These medications should initially be administered in low, incremental doses, titrated to effect, in patients with preeclampsia, aiming for a blood pressure close to baseline. The choice of vasopressor should be based on maternal hemodynamics, since the selection of specific vasopressors has not been shown to affect maternal or fetal outcomes in patients with preeclampsia [<a href="#rid49">49,50</a>].</p><p>A reasonable strategy to prevent neuraxial anesthesia-induced hypotension for patients with preeclampsia includes prophylactic, titrated administration of low-dose <a class="drug drug_general" data-topicid="9768" href="/z/d/drug information/9768.html" rel="external">phenylephrine</a> infusion (ie, starting at &lt;50 mcg/min) with rescue boluses of either phenylephrine (eg, 25 to 50 mcg IV) or <a class="drug drug_general" data-topicid="9114" href="/z/d/drug information/9114.html" rel="external">ephedrine</a> (2.5 to 5 mg IV), aiming for a blood pressure close to baseline, or systolic &lt;160 mmHg. For patients with baseline bradycardia, ephedrine (5 to 10 mg IV bolus, or 1 to 5 mg/min IV infusion) may be administered as an alternative. The choice of vasopressors for treatment of spinal hypotension is discussed in more detail separately.</p><p><a class="drug drug_general" data-topicid="9768" href="/z/d/drug information/9768.html" rel="external">Phenylephrine</a> and <a class="drug drug_general" data-topicid="9114" href="/z/d/drug information/9114.html" rel="external">ephedrine</a> are the most commonly used vasopressors to address hypotension during CD due to their long history of use and excellent maternal and fetal safety profile. However, use of <a class="drug drug_general" data-topicid="9709" href="/z/d/drug information/9709.html" rel="external">norepinephrine</a> is an area of active investigation, and there is a growing body of evidence to support its safety and noninferiority to other agents in both healthy pregnancy and in patients with preeclampsia [<a href="#rid51">51-53</a>]. (See  <a class="medical medical_review" href="/z/d/html/4480.html" rel="external">"Anesthesia for cesarean delivery", section on 'Vasopressors'</a>.)</p><p class="headingAnchor" id="H1278837048"><span class="h3">Uterotonic medications</span><span class="headingEndMark"> — </span>Uterotonic medications are routinely administered after delivery of the fetus during both vaginal and cesarean delivery. <a class="drug drug_general" data-topicid="9734" href="/z/d/drug information/9734.html" rel="external">Oxytocin</a> is the first line medication, followed by other uterotonics if bleeding persists. (See  <a class="medical medical_review" href="/z/d/html/6714.html" rel="external">"Postpartum hemorrhage: Medical and minimally invasive management", section on 'Administer additional uterotonic medications'</a>.)</p><p>The dose of <a class="drug drug_general" data-topicid="9734" href="/z/d/drug information/9734.html" rel="external">oxytocin</a> required to achieve adequate uterine tone may be increased in preeclamptic patients who receive magnesium infusions [<a href="#rid54">54</a>].</p><p><a class="drug drug_general" data-topicid="9637" href="/z/d/drug information/9637.html" rel="external">Methylergonovine</a> can cause severe hypertension, and should <strong>not</strong> be administered to patients with preeclampsia [<a href="#rid55">55</a>]. For postpartum hemorrhage unresponsive to <a class="drug drug_general" data-topicid="9734" href="/z/d/drug information/9734.html" rel="external">oxytocin</a> administration, prostaglandins (ie, <a class="drug drug_general" data-topicid="9657" href="/z/d/drug information/9657.html" rel="external">misoprostol</a> or carboprost) should be administered. Carboprost should be avoided in patients with asthma.</p><p class="headingAnchor" id="H1805503008"><span class="h2">General anesthesia</span><span class="headingEndMark"> — </span>General anesthesia may be indicated for emergency cesarean delivery with a reassuring airway examination, or for patients with severe coagulopathy such that neuraxial anesthesia is contraindicated. The basic management technique for general anesthesia for cesarean delivery is discussed separately. Concerns specific to preeclamptic patients are discussed here. (See  <a class="medical medical_review" href="/z/d/html/4480.html" rel="external">"Anesthesia for cesarean delivery", section on 'General anesthesia'</a>.)</p><p class="headingAnchor" id="H107401466"><span class="h3">Airway management</span><span class="headingEndMark"> — </span>In most patients, including those with preeclampsia, endotracheal intubation is performed after rapid sequence induction of anesthesia. Difficulty with airway management must always be anticipated, with equipment and personnel available to manage a difficult or failed airway. (See <a class="local">'Airway evaluation'</a> above and  <a class="medical medical_review" href="/z/d/html/90615.html" rel="external">"Management of the difficult airway for general anesthesia in adults"</a> and  <a class="medical medical_review" href="/z/d/html/16690.html" rel="external">"Airway management for the pregnant patient"</a>.)</p><p class="headingAnchor" id="H204530840"><span class="h3">Induction of anesthesia</span><span class="headingEndMark"> — </span>Induction of anesthesia should <strong>always</strong> include steps to minimize or eliminate the hypertensive response to laryngoscopy and intubation. This hemodynamic response may be exaggerated in preeclamptic patients, and may result in intracranial hemorrhage and/or pulmonary edema [<a href="#rid56">56,57</a>]. We place an arterial catheter in patients with severe range blood pressures for continuous blood pressure monitoring prior to induction of general anesthesia, if time permits, to facilitate rapid response to changes in blood pressure.</p><p>In addition to the usual anesthesia induction agents, a variety of medications may be administered during induction to blunt the hemodynamic response to intubation, with a target blood pressure of systolic &lt;160 mmHg and diastolic &lt;110 mmHg [<a href="#rid11">11</a>]. In general, drugs with rapid onset and short duration of action are preferred. The literature on the choice of medication and optimal doses in this setting is limited [<a href="#rid58">58</a>]. Thus, medications are chosen based on patient factors, and clinician preference.</p><p>Our usual drug regimen for induction of anesthesia is as follows:</p><p class="bulletIndent1"><span class="glyph">●</span>Preinduction, <a class="drug drug_general" data-topicid="9540" href="/z/d/drug information/9540.html" rel="external">labetalol</a> 10 mg IV boluses, titrated to achieve systolic blood pressure &lt;160 mmHg, if time permits.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><a class="drug drug_general" data-topicid="9826" href="/z/d/drug information/9826.html" rel="external">Propofol</a> 2 mg/kg IV</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><a class="drug drug_general" data-topicid="9952" href="/z/d/drug information/9952.html" rel="external">Succinylcholine</a> 1 mg/kg IV</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><a class="drug drug_general" data-topicid="9706" href="/z/d/drug information/9706.html" rel="external">Nitroglycerin</a> infusion, or <a class="drug drug_general" data-topicid="9697" href="/z/d/drug information/9697.html" rel="external">Nicardipine</a> (100 mcg/mL, 1 to 2 mL bolus), as needed during induction, with goal systolic blood pressure &lt;160 mmHg.</p><p></p><p>Medications that may be used to blunt the hypertensive response to intubation include the following:</p><p class="bulletIndent1"><span class="glyph">●</span><a class="drug drug_general" data-topicid="9540" href="/z/d/drug information/9540.html" rel="external">Labetalol</a> titrated with 10 mg IV boluses up to 1 mg/kg prior to induction [<a href="#rid59">59</a>]</p><p class="bulletIndent1"><span class="glyph">●</span><a class="drug drug_general" data-topicid="9420" href="/z/d/drug information/9420.html" rel="external">Esmolol</a> 2 mg/kg IV during induction, or 1 mg/kg IV with <a class="drug drug_general" data-topicid="9558" href="/z/d/drug information/9558.html" rel="external">lidocaine</a> [<a href="#rid60">60</a>]</p><p class="bulletIndent1"><span class="glyph">●</span><a class="drug drug_general" data-topicid="9706" href="/z/d/drug information/9706.html" rel="external">Nitroglycerin</a> 1.5 to 2.5 mcg/kg IV [<a href="#rid61">61,62</a>]</p><p class="bulletIndent1"><span class="glyph">●</span><a class="drug drug_general" data-topicid="9697" href="/z/d/drug information/9697.html" rel="external">Nicardipine</a> 15 to 30 mcg/kg IV, or 100 to 200 mcg bolus during induction [<a href="#rid63">63</a>]</p><p class="bulletIndent1"><span class="glyph">●</span><a class="drug drug_general" data-topicid="9854" href="/z/d/drug information/9854.html" rel="external">Remifentanil</a> 1 mcg/kg IV during induction [<a href="#rid64">64,65</a>], crosses the placenta and may cause transient neonatal respiratory depression</p><p class="bulletIndent1"><span class="glyph">●</span><a class="drug drug_general" data-topicid="8441" href="/z/d/drug information/8441.html" rel="external">Fentanyl</a> 1 to 3 mcg/kg IV [<a href="#rid66">66</a>]</p><p></p><p>Opioids are generally avoided during induction of anesthesia for cesarean delivery due to concerns for neonatal respiratory depression. However, clinicians should weigh that risk against the benefit of maternal hemodynamic control. In a meta-analysis of six randomized trials of elective cesarean delivery (one study in patients with preeclampsia), Apgar scores at one and five minutes were similar in patients who received <a class="drug drug_general" data-topicid="9854" href="/z/d/drug information/9854.html" rel="external">remifentanil</a> during induction and those who did not [<a href="#rid65">65</a>].</p><p>The neonatal resuscitation team should be notified of all medications administered to the mother during induction of general anesthesia.</p><p class="headingAnchor" id="H3140834780"><span class="h2">Intraoperative magnesium</span><span class="headingEndMark"> — </span><a class="drug drug_general" data-topicid="9585" href="/z/d/drug information/9585.html" rel="external">Magnesium sulfate</a> is routinely administered in the intrapartum and postpartum period to patients with preeclampsia to prevent seizures, and should be continued in the operating room during cesarean delivery [<a href="#rid30">30</a>]. (See  <a class="medical medical_review" href="/z/d/html/139247.html" rel="external">"Preeclampsia: Intrapartum and postpartum management and long-term prognosis", section on 'Seizure prophylaxis'</a>.)</p><p>Magnesium causes muscle relaxation, <strong>potentiates</strong> the effect of nondepolarizing neuromuscular blocking agents (NMBAs), and can prolong the duration of action of <a class="drug drug_general" data-topicid="9872" href="/z/d/drug information/9872.html" rel="external">rocuronium</a> [<a href="#rid67">67</a>], <a class="drug drug_general" data-topicid="9270" href="/z/d/drug information/9270.html" rel="external">cisatracurium</a> [<a href="#rid68">68</a>], and <a class="drug drug_general" data-topicid="10041" href="/z/d/drug information/10041.html" rel="external">vecuronium</a> [<a href="#rid69">69</a>]. Since nondepolarizing NMBAs are rarely necessary during cesarean delivery, they should be avoided if possible for patients who are receiving magnesium. Magnesium does not potentiate the effects of <a class="drug drug_general" data-topicid="9952" href="/z/d/drug information/9952.html" rel="external">succinylcholine</a>, and the usual rapid sequence induction dose (ie, succinylcholine 1 to 1.5 mg/kg IV) should be administered.</p><p>When muscle relaxation is required, a small additional dose of <a class="drug drug_general" data-topicid="9952" href="/z/d/drug information/9952.html" rel="external">succinylcholine</a> (10 to 20 mg IV) or deeper anesthesia may be sufficient. If a longer duration of muscle relaxation is necessary, eg, to allow for better surgical conditions prior to or during fascial closure, small incremental doses of non-depolarizing NMBA (ie, <a class="drug drug_general" data-topicid="9872" href="/z/d/drug information/9872.html" rel="external">rocuronium</a> 10 to 20 mg IV or <a class="drug drug_general" data-topicid="9270" href="/z/d/drug information/9270.html" rel="external">cisatracurium</a> 2 to 4 mg IV) should be administered, and titrated to effect using a twitch monitor with the goal of one twitch in the train of four twitches. Quantitative or qualitative monitoring should also be used at the end of surgery to ensure adequate reversal of neuromuscular blockade.</p><p>Reversal of neuromuscular blockade, including appropriate choice and dose of reversal agents, is discussed in detail separately. (See  <a class="medical medical_review" href="/z/d/html/94535.html" rel="external">"Clinical use of neuromuscular blocking agents in anesthesia", section on 'Reversal of neuromuscular block'</a>.)</p><p class="headingAnchor" id="H4178446594"><span class="h2">Postoperative pain control</span><span class="headingEndMark"> — </span>Multimodal strategies for pain control are routinely used for all patients after cesarean delivery, including those with preeclampsia, to promote rapid recovery and ambulation and to minimize the need for postoperative opioids. Pain control strategies include neuraxial <a class="drug drug_general" data-topicid="9788" href="/z/d/drug information/9788.html" rel="external">morphine</a> or <a class="drug drug_general" data-topicid="8538" href="/z/d/drug information/8538.html" rel="external">hydromorphone</a> for patients who have neuraxial anesthesia, transverse abdominis plane blocks, quadratus lumborum blocks, <a class="drug drug_general" data-topicid="9242" href="/z/d/drug information/9242.html" rel="external">acetaminophen</a>, nonsteroidal antiinflammatory drugs (NSAIDs), and systemic opioids. (See  <a class="medical medical_review" href="/z/d/html/4480.html" rel="external">"Anesthesia for cesarean delivery", section on 'Post-cesarean delivery analgesia'</a>.)</p><p>We routinely administer NSAIDs (<a class="drug drug_general" data-topicid="8591" href="/z/d/drug information/8591.html" rel="external">ketorolac</a> 15 to 30 mg IV every six hours as needed, or <a class="drug drug_general" data-topicid="8547" href="/z/d/drug information/8547.html" rel="external">ibuprofen</a> 600 to 800 mg orally every six hours as needed) for 48 hours after cesarean delivery, and avoid NSAIDs for patients with significant blood loss during cesarean delivery, thrombocytopenia or other risk factors for bleeding.</p><p>NSAIDs are opioid sparing, and are especially effective for relief of uterine cramping, though these medications interfere with platelet function. (See  <a class="medical medical_review" href="/z/d/html/2385.html" rel="external">"NSAIDs and acetaminophen: Effects on blood pressure and hypertension", section on 'Effect of NSAIDs on blood pressure'</a>.)</p><p>A 2020 Practice Bulletin from the American Congress of Obstetricians and Gynecologists (ACOG) recommends the use of NSAIDS preferentially over opioids for postpartum pain in patients with hypertensive disorders, including preeclampsia [<a href="#rid22">22</a>]. Several studies of the use of NSAIDS in patients with preeclampsia have found no association between NSAIDs and postpartum blood pressure elevation or other adverse effects [<a href="#rid70">70-72</a>].</p><p class="headingAnchor" id="H2071999559"><span class="h1">POSTPARTUM CARE</span><span class="headingEndMark"> — </span>The risks for complications of preeclampsia continue into the postpartum period. These patients may remain hypertensive and are at risk for seizures, pulmonary edema, stroke, venous thromboembolism, and airway obstruction due to airway edema. (See  <a class="medical medical_review" href="/z/d/html/139247.html" rel="external">"Preeclampsia: Intrapartum and postpartum management and long-term prognosis", section on 'Postpartum care'</a>.)</p><p>For patients who undergo cesarean delivery, postoperative disposition (eg, post anesthesia recovery unit, intensive care unit) should be determined by the intraoperative course, patient factors, the need for ongoing invasive monitoring, and available resources.</p><p class="headingAnchor" id="H3197020591"><span class="h1">ECLAMPSIA</span><span class="headingEndMark"> — </span>Eclampsia refers to the occurrence of new-onset, generalized, tonic-clonic seizures or coma in a woman with preeclampsia. The precise etiology of seizures in eclampsia is not clearly understood, and may involve brain edema and/or ischemia. Obstetric management of eclampsia is discussed separately. (See  <a class="medical medical_review" href="/z/d/html/1662.html" rel="external">"Eclampsia"</a>.)</p><p>Anesthesia clinicians may be called to manage the airway during an eclamptic seizure, or to provide anesthesia for vaginal or cesarean delivery [<a href="#rid73">73</a>]. Cesarean delivery should be delayed to allow maternal assessment and stabilization if a seizure occurs. Patients who do not improve promptly following control of hypertension and seizures and those who develop localizing neurologic signs should be evaluated by a neurologist for possible imaging to rule out stroke.</p><p>Seizures may rarely occur during cesarean delivery with neuraxial anesthesia. Treatment priorities in this setting are the same as the priorities for patients without anesthesia, as follows (see  <a class="medical medical_review" href="/z/d/html/1662.html" rel="external">"Eclampsia", section on 'Prevention of recurrent seizures'</a> and  <a class="medical medical_review" href="/z/d/html/1662.html" rel="external">"Eclampsia", section on 'Management'</a>):</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Airway protection and prevention of hypoxia</strong> — Supplemental oxygen should be provided and the airway supported until the seizure ends.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Control of hypertension </strong>— Blood pressure control should be meticulously maintained at &lt;160 mmHg systolic</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Prevention of recurrent seizures</strong> — Magnesium is the drug of choice for prevention of seizures. A loading dose of <a class="drug drug_general" data-topicid="9585" href="/z/d/drug information/9585.html" rel="external">magnesium sulfate</a> 4 to 6 g intravenous (IV) should be administered over 15 to 20 minutes, followed by 2 g per hour as a continuous infusion. (See  <a class="medical medical_review" href="/z/d/html/1662.html" rel="external">"Eclampsia", section on 'Dosing and toxicity'</a>.)</p><p></p><p class="bulletIndent1">For recurrent seizures in patients already receiving magnesium, an additional dose of 2 g <a class="drug drug_general" data-topicid="9585" href="/z/d/drug information/9585.html" rel="external">magnesium sulfate</a> over 5 to 10 minutes should be administered, with frequent monitoring for signs of magnesium toxicity. If necessary, a seizure may be terminated with benzodiazepines, most commonly <a class="drug drug_general" data-topicid="9650" href="/z/d/drug information/9650.html" rel="external">midazolam</a> 1 to 2 mg IV, repeated every five minutes until the seizure stops. (See  <a class="medical medical_review" href="/z/d/html/1662.html" rel="external">"Eclampsia", section on 'Prevention of recurrent seizures'</a> and  <a class="medical medical_review" href="/z/d/html/1662.html" rel="external">"Eclampsia", section on 'Management of recurrent seizures'</a>.)</p><p></p><p class="headingAnchor" id="H549584976"><span class="h1">SOCIETY GUIDELINE LINKS</span><span class="headingEndMark"> — </span>Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See  <a class="medical medical_society_guidelines" href="/z/d/html/109729.html" rel="external">"Society guideline links: Hypertensive disorders of pregnancy"</a> and  <a class="medical medical_society_guidelines" href="/z/d/html/131710.html" rel="external">"Society guideline links: Obstetric anesthesia"</a>.)</p><p class="headingAnchor" id="H1977330632"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Preanesthesia evaluation</strong></p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Anesthesia clinicians should evaluate patients with preeclampsia early in the peripartum period, with the expectation that emergency delivery may be required at any time. The evaluation should focus on the airway, hemodynamic status, and coagulation abnormalities. (See <a class="local">'Preanesthesia evaluation'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Patients with preeclampsia are at risk for airway edema and difficulty with airway management. Airway edema may worsen during labor and delivery. (See <a class="local">'Airway evaluation'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Thrombocytopenia and other coagulopathies may develop with severe preeclampsia, and may preclude neuraxial anesthesia techniques because of the risk of spinal epidural hematoma. We place epidural catheters early in labor, especially for patients with falling platelet counts. In the absence of other coagulopathies, we place epidural catheters for patients with a platelet count &gt;70,000/microL, do not perform neuraxial techniques if the platelet count is ≤50,000/microL, and make individualized decisions for patients with a platelet count between 50,000 and 70,000/microL. (See <a class="local">'Coagulation'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Intravenous fluid and blood pressure management</strong></p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Intravenous (IV) fluid administration should be restricted for patients with preeclampsia to avoid pulmonary edema. No fluid bolus is required for initiation of labor analgesia, and fluid co-loading with neuraxial anesthesia for cesarean delivery should be avoided or limited to &lt;500 mL. (See <a class="local">'Intravenous fluid management'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>For patients with preeclampsia, we target a blood pressure at the patient's baseline, but always systolic &lt;160 mmHg and diastolic &lt;110 mmHg. (See <a class="local">'Goal blood pressure'</a> above.)</p><p></p><p class="bulletIndent3"><span class="glyph">-</span><a class="drug drug_general" data-topicid="9540" href="/z/d/drug information/9540.html" rel="external">Labetalol</a>, <a class="drug drug_general" data-topicid="8528" href="/z/d/drug information/8528.html" rel="external">hydralazine</a> and <a class="drug drug_general" data-topicid="9700" href="/z/d/drug information/9700.html" rel="external">nifedipine</a> are reasonable choices for treatment of hypertension. (See <a class="local">'Hemodynamic status'</a> above and  <a class="medical medical_review" href="/z/d/html/6815.html" rel="external">"Treatment of hypertension in pregnant and postpartum patients", section on 'Choice of therapy'</a>.)</p><p></p><p class="bulletIndent3"><span class="glyph">-</span>Vasopressors should be administered in small doses (eg, <a class="drug drug_general" data-topicid="9114" href="/z/d/drug information/9114.html" rel="external">ephedrine</a> 2.5 to 5 mg IV, <a class="drug drug_general" data-topicid="9768" href="/z/d/drug information/9768.html" rel="external">phenylephrine</a> 25 to 50 mcg IV). (See <a class="local">'Vasopressors during neuraxial analgesia'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Labor analgesia </strong>–<strong> </strong>We suggest the use of neuraxial analgesia for labor for patients with preeclampsia (<a class="grade" href="https:///uptodate/show/grade_6" rel="external">Grade 2C</a>). Continuous neuraxial analgesia attenuates the hypertensive response to labor pain and circulating catecholamines, and provides a means for rapid conversion to surgical neuraxial anesthesia and avoidance of general anesthesia. (See <a class="local">'Advantages of neuraxial labor analgesia'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Anesthesia for cesarean delivery</strong></p><p></p><p class="bulletIndent2"><span class="glyph">•</span>For patients with preeclampsia who undergo cesarean delivery, we recommend neuraxial anesthesia rather than general anesthesia (<a class="grade" href="https:///uptodate/show/grade_2" rel="external">Grade 1B</a>), primarily because it avoids the risk of severe, possibly life threatening hypertension during induction of anesthesia or during emergence. Endotracheal intubation may be difficult in these edematous patients. Spinal, epidural, and combined spinal-epidural may all be used safely. (See <a class="local">'Choice of anesthetic technique'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>For prevention of neuraxial anesthesia-induced hypotension for patients with preeclampsia, we administer a prophylactic, titrated administration of low-dose <a class="drug drug_general" data-topicid="9768" href="/z/d/drug information/9768.html" rel="external">phenylephrine</a> infusion (ie, starting at &lt;50 mcg/min) with phenylephrine rescue boluses (eg, 25 to 50 mcg IV). For patients with bradycardia, <a class="drug drug_general" data-topicid="9114" href="/z/d/drug information/9114.html" rel="external">ephedrine</a> (5 to 10 mg IV bolus, or 1 to 5 mg/min IV infusion) should be administered as an alternative.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>When time permits, we consider placement of an arterial catheter prior to induction of general anesthesia for patients with severe preeclampsia. Induction of general anesthesia for these patients should always include steps to minimize or eliminate the hypertensive response to intubation. A variety of medications may be administered during induction for this purpose, with a target systolic blood pressure &lt;160 mmHg (eg, <a class="drug drug_general" data-topicid="9540" href="/z/d/drug information/9540.html" rel="external">labetalol</a>, <a class="drug drug_general" data-topicid="9420" href="/z/d/drug information/9420.html" rel="external">esmolol</a>, <a class="drug drug_general" data-topicid="9706" href="/z/d/drug information/9706.html" rel="external">nitroglycerin</a>, <a class="drug drug_general" data-topicid="9697" href="/z/d/drug information/9697.html" rel="external">nicardipine</a>). (See <a class="local">'Induction of anesthesia'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Magnesium therapy </strong>–<strong> </strong>Magnesium is routinely administered to prevent seizures in preeclamptic patients. We recommend continuing magnesium in the operating room during cesarean delivery (<a class="grade" href="https:///uptodate/show/grade_1" rel="external">Grade 1A</a>). Magnesium <strong>potentiates</strong> nondepolarizing neuromuscular blocking agents (NMBAs). If NMBAs are absolutely necessary, they should be administered in small, incremental doses, and the effect should be monitored with a peripheral nerve stimulator. (See <a class="local">'Intraoperative magnesium'</a> above.)</p><p></p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Estcourt LJ, Malouf R, Hopewell S, et al. Use of platelet transfusions prior to lumbar punctures or epidural anaesthesia for the prevention of complications in people with thrombocytopenia. Cochrane Database Syst Rev 2018; 4:CD011980.</a></li><li><a class="nounderline abstract_t">Lee LO, Bateman BT, Kheterpal S, et al. Risk of Epidural Hematoma after Neuraxial Techniques in Thrombocytopenic Parturients: A Report from the Multicenter Perioperative Outcomes Group. Anesthesiology 2017; 126:1053.</a></li><li><a class="nounderline abstract_t">Bauer ME, Arendt K, Beilin Y, et al. The Society for Obstetric Anesthesia and Perinatology Interdisciplinary Consensus Statement on Neuraxial Procedures in Obstetric Patients With Thrombocytopenia. Anesth Analg 2021; 132:1531.</a></li><li><a class="nounderline abstract_t">US Preventive Services Task Force, Davidson KW, Barry MJ, et al. Aspirin Use to Prevent Preeclampsia and Related Morbidity and Mortality: US Preventive Services Task Force Recommendation Statement. JAMA 2021; 326:1186.</a></li><li class="breakAll">American College of Obstetricians and Gynecologists' Practice Advisory: Low-Dose Aspirin Use for the Prevention of Preeclampsia and Related Morbidity and Mortality. December 2021. https://www.acog.org/clinical/clinical-guidance/practice-advisory/articles/2021/12/low-dose-aspirin-use-for-the-prevention-of-preeclampsia-and-related-morbidity-and-mortality (Accessed on December 21, 2021).</li><li><a class="nounderline abstract_t">Leduc L, Wheeler JM, Kirshon B, et al. Coagulation profile in severe preeclampsia. Obstet Gynecol 1992; 79:14.</a></li><li><a class="nounderline abstract_t">Barron WM, Heckerling P, Hibbard JU, Fisher S. Reducing unnecessary coagulation testing in hypertensive disorders of pregnancy. Obstet Gynecol 1999; 94:364.</a></li><li><a class="nounderline abstract_t">Nuttall G, Burckhardt J, Hadley A, et al. Surgical and Patient Risk Factors for Severe Arterial Line Complications in Adults. Anesthesiology 2016; 124:590.</a></li><li><a class="nounderline abstract_t">Martin JN Jr, Thigpen BD, Moore RC, et al. Stroke and severe preeclampsia and eclampsia: a paradigm shift focusing on systolic blood pressure. Obstet Gynecol 2005; 105:246.</a></li><li><a class="nounderline abstract_t">Judy AE, McCain CL, Lawton ES, et al. Systolic Hypertension, Preeclampsia-Related Mortality, and Stroke in California. Obstet Gynecol 2019; 133:1151.</a></li><li><a class="nounderline abstract_t">Committee Opinion No. 692 Summary: Emergent Therapy for Acute-Onset, Severe Hypertension During Pregnancy and the Postpartum Period. Obstet Gynecol 2017; 129:769.</a></li><li><a class="nounderline abstract_t">Invasive hemodynamic monitoring in obstetrics and gynecology. ACOG Technical Bulletin Number 175--December 1992. Int J Gynaecol Obstet 1993; 42:199.</a></li><li><a class="nounderline abstract_t">Gilbert WM, Towner DR, Field NT, Anthony J. The safety and utility of pulmonary artery catheterization in severe preeclampsia and eclampsia. Am J Obstet Gynecol 2000; 182:1397.</a></li><li><a class="nounderline abstract_t">Chestnut DH, Lumb PD, Jelovsek F, Killam AP. Nonbacterial thrombotic endocarditis associated with severe preeclampsia and pulmonary artery catheterization. A case report. J Reprod Med 1985; 30:497.</a></li><li><a class="nounderline abstract_t">Li YH, Novikova N. Pulmonary artery flow catheters for directing management in pre-eclampsia. Cochrane Database Syst Rev 2012; :CD008882.</a></li><li><a class="nounderline abstract_t">Benedetti TJ, Cotton DB, Read JC, Miller FC. Hemodynamic observations in severe pre-eclampsia with a flow-directed pulmonary artery catheter. Am J Obstet Gynecol 1980; 136:465.</a></li><li><a class="nounderline abstract_t">Bolte AC, Dekker GA, van Eyck J, et al. Lack of agreement between central venous pressure and pulmonary capillary wedge pressure in preeclampsia. Hypertens Pregnancy 2000; 19:261.</a></li><li><a class="nounderline abstract_t">Cotton DB, Gonik B, Dorman K, Harrist R. Cardiovascular alterations in severe pregnancy-induced hypertension: relationship of central venous pressure to pulmonary capillary wedge pressure. Am J Obstet Gynecol 1985; 151:762.</a></li><li><a class="nounderline abstract_t">Regitz-Zagrosek V, Roos-Hesselink JW, Bauersachs J, et al. 2018 ESC Guidelines for the management of cardiovascular diseases during pregnancy. Eur Heart J 2018; 39:3165.</a></li><li><a class="nounderline abstract_t">Writing Group Members, Doherty JU, Kort S, et al. ACC/AATS/AHA/ASE/ASNC/HRS/SCAI/SCCT/SCMR/STS 2019 Appropriate Use Criteria for Multimodality Imaging in the Assessment of Cardiac Structure and Function in Nonvalvular Heart Disease: A Report of the American College of Cardiology Appropriate Use Criteria Task Force, American Association for Thoracic Surgery, American Heart Association, American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Rhythm Society, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Computed Tomography, Society for Cardiovascular Magnetic Resonance, and the Society of Thoracic Surgeons. J Am Soc Echocardiogr 2019; 32:553.</a></li><li><a class="nounderline abstract_t">Vaught AJ, Kovell LC, Szymanski LM, et al. Acute Cardiac Effects of Severe Pre-Eclampsia. J Am Coll Cardiol 2018; 72:1.</a></li><li><a class="nounderline abstract_t">Gestational Hypertension and Preeclampsia: ACOG Practice Bulletin, Number 222. Obstet Gynecol 2020; 135:e237. Reaffirmed 2023.</a></li><li><a class="nounderline abstract_t">Hofmeyr G, Cyna A, Middleton P. Prophylactic intravenous preloading for regional analgesia in labour. Cochrane Database Syst Rev 2004; :CD000175.</a></li><li class="breakAll">National Collaborating Centre for Women's and Children's Health. Hypertension in pregnancy. The management of hypertensive disorders during pregnancy. London (UK): National Institute for Health and Clinical Excellence (NICE); 2011 (Clinical guideline; no. 107). https://www.nice.org.uk/guidance/cg107 (Accessed on June 28, 2018).</li><li><a class="nounderline abstract_t">McDonald S, Fernando R, Ashpole K, Columb M. Maternal cardiac output changes after crystalloid or colloid coload following spinal anesthesia for elective cesarean delivery: a randomized controlled trial. Anesth Analg 2011; 113:803.</a></li><li><a class="nounderline abstract_t">Loubert C. Fluid and vasopressor management for Cesarean delivery under spinal anesthesia: continuing professional development. Can J Anaesth 2012; 59:604.</a></li><li><a class="nounderline abstract_t">Duley L, Williams J, Henderson-Smart DJ. Plasma volume expansion for treatment of women with pre-eclampsia. Cochrane Database Syst Rev 2000; :CD001805.</a></li><li><a class="nounderline abstract_t">Ganzevoort W, Rep A, Bonsel GJ, et al. A randomised controlled trial comparing two temporising management strategies, one with and one without plasma volume expansion, for severe and early onset pre-eclampsia. BJOG 2005; 112:1358.</a></li><li><a class="nounderline abstract_t">Pretorius T, van Rensburg G, Dyer RA, Biccard BM. The influence of fluid management on outcomes in preeclampsia: a systematic review and meta-analysis. Int J Obstet Anesth 2018; 34:85.</a></li><li class="breakAll">American College of Obstetricians and Gynecologists. Hypertension in Pregnancy. http://www.acog.org/Resources-And-Publications/Task-Force-and-Work-Group-Reports/Hypertension-in-Pregnancy (Accessed on August 24, 2016).</li><li><a class="nounderline abstract_t">Jones L, Othman M, Dowswell T, et al. Pain management for women in labour: an overview of systematic reviews. Cochrane Database Syst Rev 2012; :CD009234.</a></li><li><a class="nounderline abstract_t">Shnider SM, Abboud TK, Artal R, et al. Maternal catecholamines decrease during labor after lumbar epidural anesthesia. Am J Obstet Gynecol 1983; 147:13.</a></li><li><a class="nounderline abstract_t">Lederman RP, Lederman E, Work B Jr, McCann DS. Anxiety and epinephrine in multiparous women in labor: relationship to duration of labor and fetal heart rate pattern. Am J Obstet Gynecol 1985; 153:870.</a></li><li><a class="nounderline abstract_t">Jouppila R, Jouppila P, Hollmén A, Kuikka J. Effect of segmental extradural analgesia on placental blood flow during normal labour. Br J Anaesth 1978; 50:563.</a></li><li><a class="nounderline abstract_t">Gude P, Kaci CSB, Sieker M, et al. The influence of labor epidural analgesia on maternal, uteroplacental and fetoplacental hemodynamics in normotensive parturients: a prospective observational study. Int J Obstet Anesth 2021; 45:83.</a></li><li><a class="nounderline abstract_t">Patel P, Desai P, Gajjar F. Labor epidural analgesia in pre-eclampsia: a prospective study. J Obstet Gynaecol Res 2005; 31:291.</a></li><li><a class="nounderline abstract_t">Head BB, Owen J, Vincent RD Jr, et al. A randomized trial of intrapartum analgesia in women with severe preeclampsia. Obstet Gynecol 2002; 99:452.</a></li><li><a class="nounderline abstract_t">El-Kerdawy H, Farouk A. Labor analgesia in preeclampsia: remifentanil patient controlled intravenous analgesia versus epidural analgesia. Middle East J Anaesthesiol 2010; 20:539.</a></li><li><a class="nounderline abstract_t">Lucas MJ, Sharma SK, McIntire DD, et al. A randomized trial of labor analgesia in women with pregnancy-induced hypertension. Am J Obstet Gynecol 2001; 185:970.</a></li><li><a class="nounderline abstract_t">VanWijk MJ, Boer K, van der Meulen ET, et al. Resistance artery smooth muscle function in pregnancy and preeclampsia. Am J Obstet Gynecol 2002; 186:148.</a></li><li><a class="nounderline abstract_t">Nisell H, Hjemdahl P, Linde B. Cardiovascular responses to circulating catecholamines in normal pregnancy and in pregnancy-induced hypertension. Clin Physiol 1985; 5:479.</a></li><li><a class="nounderline abstract_t">Aya AG, Vialles N, Tanoubi I, et al. Spinal anesthesia-induced hypotension: a risk comparison between patients with severe preeclampsia and healthy women undergoing preterm cesarean delivery. Anesth Analg 2005; 101:869.</a></li><li><a class="nounderline abstract_t">Aya AG, Mangin R, Vialles N, et al. Patients with severe preeclampsia experience less hypotension during spinal anesthesia for elective cesarean delivery than healthy parturients: a prospective cohort comparison. Anesth Analg 2003; 97:867.</a></li><li><a class="nounderline abstract_t">Clark VA, Sharwood-Smith GH, Stewart AV. Ephedrine requirements are reduced during spinal anaesthesia for caesarean section in preeclampsia. Int J Obstet Anesth 2005; 14:9.</a></li><li><a class="nounderline abstract_t">Dyer RA, Els I, Farbas J, et al. Prospective, randomized trial comparing general with spinal anesthesia for cesarean delivery in preeclamptic patients with a nonreassuring fetal heart trace. Anesthesiology 2003; 99:561.</a></li><li><a class="nounderline abstract_t">Wallace DH, Leveno KJ, Cunningham FG, et al. Randomized comparison of general and regional anesthesia for cesarean delivery in pregnancies complicated by severe preeclampsia. Obstet Gynecol 1995; 86:193.</a></li><li><a class="nounderline abstract_t">Visalyaputra S, Rodanant O, Somboonviboon W, et al. Spinal versus epidural anesthesia for cesarean delivery in severe preeclampsia: a prospective randomized, multicenter study. Anesth Analg 2005; 101:862.</a></li><li><a class="nounderline abstract_t">Hood DD, Curry R. Spinal versus epidural anesthesia for cesarean section in severely preeclamptic patients: a retrospective survey. Anesthesiology 1999; 90:1276.</a></li><li><a class="nounderline abstract_t">Mohta M, Duggal S, Chilkoti GT. Randomised double-blind comparison of bolus phenylephrine or ephedrine for treatment of hypotension in women with pre-eclampsia undergoing caesarean section. Anaesthesia 2018; 73:839.</a></li><li><a class="nounderline abstract_t">Higgins N, Fitzgerald PC, van Dyk D, et al. The Effect of Prophylactic Phenylephrine and Ephedrine Infusions on Umbilical Artery Blood pH in Women With Preeclampsia Undergoing Cesarean Delivery With Spinal Anesthesia: A Randomized, Double-Blind Trial. Anesth Analg 2018; 126:1999.</a></li><li><a class="nounderline abstract_t">Ngan Kee WD, Lee SWY, Ng FF, Lee A. Norepinephrine or phenylephrine during spinal anaesthesia for Caesarean delivery: a randomised double-blind pragmatic non-inferiority study of neonatal outcome. Br J Anaesth 2020; 125:588.</a></li><li><a class="nounderline abstract_t">Guo L, Qin R, Ren X, et al. Prophylactic norepinephrine or phenylephrine infusion for bradycardia and post-spinal anaesthesia hypotension in patients with preeclampsia during Caesarean delivery: a randomised controlled trial. Br J Anaesth 2022; 128:e305.</a></li><li><a class="nounderline abstract_t">Fu F, Yang MJ, Xu LL, Chen XZ. A comparison of the effect of phenylephrine and norepinephrine on uteroplacental vascular resistance during the treatment of postspinal hypotension in preeclamptic patients: A randomised controlled study. Eur J Anaesthesiol 2024; 41:150.</a></li><li><a class="nounderline abstract_t">Tyagi A, Mohan A, Singh Y, et al. Effective Dose of Prophylactic Oxytocin Infusion During Cesarean Delivery in 90% Population of Nonlaboring Patients With Preeclampsia Receiving Magnesium Sulfate Therapy and Normotensives: An Up-Down Sequential Allocation Dose-Response Study. Anesth Analg 2022; 134:303.</a></li><li><a class="nounderline abstract_t">Liabsuetrakul T, Choobun T, Peeyananjarassri K, Islam QM. Prophylactic use of ergot alkaloids in the third stage of labour. Cochrane Database Syst Rev 2018; 6:CD005456.</a></li><li class="breakAll">The Seventh Report on Confidential Enquiry into Maternal and Child Health (CEMACH). Saving Mothers' Lives: Reviewing maternal deaths to make motherhood safer - 2003-2005. http://www.publichealth.hscni.net/sites/default/files/Saving%20Mothers'%20Lives%202003-05%20.pdf (Accessed on August 24, 2016).</li><li><a class="nounderline abstract_t">Cantwell R, Clutton-Brock T, Cooper G, et al. Saving Mothers' Lives: Reviewing maternal deaths to make motherhood safer: 2006-2008. The Eighth Report of the Confidential Enquiries into Maternal Deaths in the United Kingdom. BJOG 2011; 118 Suppl 1:1.</a></li><li><a class="nounderline abstract_t">Pant M, Fong R, Scavone B. Prevention of peri-induction hypertension in preeclamptic patients: a focused review. Anesth Analg 2014; 119:1350.</a></li><li><a class="nounderline abstract_t">Ramanathan J, Sibai BM, Mabie WC, et al. The use of labetalol for attenuation of the hypertensive response to endotracheal intubation in preeclampsia. Am J Obstet Gynecol 1988; 159:650.</a></li><li><a class="nounderline abstract_t">Bansal S, Pawar M. Haemodynamic responses to laryngoscopy and intubation in patients with pregnancy-induced hypertension: effect of intravenous esmolol with or without lidocaine. Int J Obstet Anesth 2002; 11:4.</a></li><li><a class="nounderline abstract_t">Hood DD, Dewan DM, James FM 3rd, et al. The use of nitroglycerin in preventing the hypertensive response to tracheal intubation in severe preeclampsia. Anesthesiology 1985; 63:329.</a></li><li><a class="nounderline abstract_t">Safavi M, Honarmand A, Azari N. Attenuation of the pressor response to tracheal intubation in severe preeclampsia: relative efficacies of nitroglycerine infusion, sublingual nifedipine, and intravenous hydralazine. Anesth Pain Med 2011; 1:81.</a></li><li><a class="nounderline abstract_t">Curran MP, Robinson DM, Keating GM. Intravenous nicardipine: its use in the short-term treatment of hypertension and various other indications. Drugs 2006; 66:1755.</a></li><li><a class="nounderline abstract_t">Heesen M, Klöhr S, Hofmann T, et al. Maternal and foetal effects of remifentanil for general anaesthesia in parturients undergoing caesarean section: a systematic review and meta-analysis. Acta Anaesthesiol Scand 2013; 57:29.</a></li><li><a class="nounderline abstract_t">White LD, Hodsdon A, An GH, et al. Induction opioids for caesarean section under general anaesthesia: a systematic review and meta-analysis of randomised controlled trials. Int J Obstet Anesth 2019; 40:4.</a></li><li><a class="nounderline abstract_t">Rout CC, Rocke DA. Effects of alfentanil and fentanyl on induction of anaesthesia in patients with severe pregnancy-induced hypertension. Br J Anaesth 1990; 65:468.</a></li><li><a class="nounderline abstract_t">Czarnetzki C, Lysakowski C, Elia N, Tramèr MR. Time course of rocuronium-induced neuromuscular block after pre-treatment with magnesium sulphate: a randomised study. Acta Anaesthesiol Scand 2010; 54:299.</a></li><li><a class="nounderline abstract_t">Pinard AM, Donati F, Martineau R, et al. Magnesium potentiates neuromuscular blockade with cisatracurium during cardiac surgery. Can J Anaesth 2003; 50:172.</a></li><li><a class="nounderline abstract_t">Fuchs-Buder T, Wilder-Smith OH, Borgeat A, Tassonyi E. Interaction of magnesium sulphate with vecuronium-induced neuromuscular block. Br J Anaesth 1995; 74:405.</a></li><li><a class="nounderline abstract_t">Viteri OA, England JA, Alrais MA, et al. Association of Nonsteroidal Antiinflammatory Drugs and Postpartum Hypertension in Women With Preeclampsia With Severe Features. Obstet Gynecol 2017; 130:830.</a></li><li><a class="nounderline abstract_t">Penfield CA, McNulty JA, Oakes MC, Nageotte MP. Ibuprofen and Postpartum Blood Pressure in Women With Hypertensive Disorders of Pregnancy: A Randomized Controlled Trial. Obstet Gynecol 2019; 134:1219.</a></li><li><a class="nounderline abstract_t">Blue NR, Murray-Krezan C, Drake-Lavelle S, et al. Effect of ibuprofen vs acetaminophen on postpartum hypertension in preeclampsia with severe features: a double-masked, randomized controlled trial. Am J Obstet Gynecol 2018; 218:616.e1.</a></li><li><a class="nounderline abstract_t">Podovei M, Bateman BT. The Consensus Bundle on Hypertension in Pregnancy and the Anesthesiologist: Doing All the Right Things for All the Patients All of the Time. Anesth Analg 2017; 125:383.</a></li></ol></div><div id="topicVersionRevision">Topic 94369 Version 24.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29709077" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Use of platelet transfusions prior to lumbar punctures or epidural anaesthesia for the prevention of complications in people with thrombocytopenia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28383323" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Risk of Epidural Hematoma after Neuraxial Techniques in Thrombocytopenic Parturients: A Report from the Multicenter Perioperative Outcomes Group.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33861047" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : The Society for Obstetric Anesthesia and Perinatology Interdisciplinary Consensus Statement on Neuraxial Procedures in Obstetric Patients With Thrombocytopenia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34581729" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Aspirin Use to Prevent Preeclampsia and Related Morbidity and Mortality: US Preventive Services Task Force Recommendation Statement.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34581729" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Aspirin Use to Prevent Preeclampsia and Related Morbidity and Mortality: US Preventive Services Task Force Recommendation Statement.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1727573" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Coagulation profile in severe preeclampsia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10472861" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Reducing unnecessary coagulation testing in hypertensive disorders of pregnancy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26640979" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Surgical and Patient Risk Factors for Severe Arterial Line Complications in Adults.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15684147" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Stroke and severe preeclampsia and eclampsia: a paradigm shift focusing on systolic blood pressure.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31135728" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Systolic Hypertension, Preeclampsia-Related Mortality, and Stroke in California.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28333812" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Committee Opinion No. 692 Summary: Emergent Therapy for Acute-Onset, Severe Hypertension During Pregnancy and the Postpartum Period.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7901074" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Invasive hemodynamic monitoring in obstetrics and gynecology. ACOG Technical Bulletin Number 175--December 1992.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10871455" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : The safety and utility of pulmonary artery catheterization in severe preeclampsia and eclampsia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/4020793" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Nonbacterial thrombotic endocarditis associated with severe preeclampsia and pulmonary artery catheterization. A case report.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22696380" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Pulmonary artery flow catheters for directing management in pre-eclampsia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7355925" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Hemodynamic observations in severe pre-eclampsia with a flow-directed pulmonary artery catheter.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11118399" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Lack of agreement between central venous pressure and pulmonary capillary wedge pressure in preeclampsia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3976788" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Cardiovascular alterations in severe pregnancy-induced hypertension: relationship of central venous pressure to pulmonary capillary wedge pressure.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30165544" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : 2018 ESC Guidelines for the management of cardiovascular diseases during pregnancy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30744922" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : ACC/AATS/AHA/ASE/ASNC/HRS/SCAI/SCCT/SCMR/STS 2019 Appropriate Use Criteria for Multimodality Imaging in the Assessment of Cardiac Structure and Function in Nonvalvular Heart Disease: A Report of the American College of Cardiology Appropriate Use Criteria Task Force, American Association for Thoracic Surgery, American Heart Association, American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Rhythm Society, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Computed Tomography, Society for Cardiovascular Magnetic Resonance, and the Society of Thoracic Surgeons.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29957219" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Acute Cardiac Effects of Severe Pre-Eclampsia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32443079" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Gestational Hypertension and Preeclampsia: ACOG Practice Bulletin, Number 222.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15494990" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Prophylactic intravenous preloading for regional analgesia in labour.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15494990" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Prophylactic intravenous preloading for regional analgesia in labour.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21890886" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Maternal cardiac output changes after crystalloid or colloid coload following spinal anesthesia for elective cesarean delivery: a randomized controlled trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22528166" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Fluid and vasopressor management for Cesarean delivery under spinal anesthesia: continuing professional development.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10796272" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Plasma volume expansion for treatment of women with pre-eclampsia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16167938" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : A randomised controlled trial comparing two temporising management strategies, one with and one without plasma volume expansion, for severe and early onset pre-eclampsia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29398426" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : The influence of fluid management on outcomes in preeclampsia: a systematic review and meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29398426" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : The influence of fluid management on outcomes in preeclampsia: a systematic review and meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22419342" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Pain management for women in labour: an overview of systematic reviews.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6614080" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Maternal catecholamines decrease during labor after lumbar epidural anesthesia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/4073158" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Anxiety and epinephrine in multiparous women in labor: relationship to duration of labor and fetal heart rate pattern.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/666930" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : Effect of segmental extradural analgesia on placental blood flow during normal labour.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33298344" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : The influence of labor epidural analgesia on maternal, uteroplacental and fetoplacental hemodynamics in normotensive parturients: a prospective observational study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16018774" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : Labor epidural analgesia in pre-eclampsia: a prospective study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11864673" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : A randomized trial of intrapartum analgesia in women with severe preeclampsia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20394251" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : Labor analgesia in preeclampsia: remifentanil patient controlled intravenous analgesia versus epidural analgesia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11641687" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : A randomized trial of labor analgesia in women with pregnancy-induced hypertension.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11810101" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : Resistance artery smooth muscle function in pregnancy and preeclampsia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/4053528" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : Cardiovascular responses to circulating catecholamines in normal pregnancy and in pregnancy-induced hypertension.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16116006" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : Spinal anesthesia-induced hypotension: a risk comparison between patients with severe preeclampsia and healthy women undergoing preterm cesarean delivery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12933418" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : Patients with severe preeclampsia experience less hypotension during spinal anesthesia for elective cesarean delivery than healthy parturients: a prospective cohort comparison.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15627532" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : Ephedrine requirements are reduced during spinal anaesthesia for caesarean section in preeclampsia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12960539" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : Prospective, randomized trial comparing general with spinal anesthesia for cesarean delivery in preeclamptic patients with a nonreassuring fetal heart trace.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7617349" id="rid45" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>46 : Randomized comparison of general and regional anesthesia for cesarean delivery in pregnancies complicated by severe preeclampsia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16116005" id="rid46" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>47 : Spinal versus epidural anesthesia for cesarean delivery in severe preeclampsia: a prospective randomized, multicenter study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10319773" id="rid47" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>48 : Spinal versus epidural anesthesia for cesarean section in severely preeclamptic patients: a retrospective survey.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29520867" id="rid48" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>49 : Randomised double-blind comparison of bolus phenylephrine or ephedrine for treatment of hypotension in women with pre-eclampsia undergoing caesarean section.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28953494" id="rid49" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>50 : The Effect of Prophylactic Phenylephrine and Ephedrine Infusions on Umbilical Artery Blood pH in Women With Preeclampsia Undergoing Cesarean Delivery With Spinal Anesthesia: A Randomized, Double-Blind Trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32682556" id="rid50" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>51 : Norepinephrine or phenylephrine during spinal anaesthesia for Caesarean delivery: a randomised double-blind pragmatic non-inferiority study of neonatal outcome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35190176" id="rid51" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>52 : Prophylactic norepinephrine or phenylephrine infusion for bradycardia and post-spinal anaesthesia hypotension in patients with preeclampsia during Caesarean delivery: a randomised controlled trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/38164096" id="rid52" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>53 : A comparison of the effect of phenylephrine and norepinephrine on uteroplacental vascular resistance during the treatment of postspinal hypotension in preeclamptic patients: A randomised controlled study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34469334" id="rid53" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>54 : Effective Dose of Prophylactic Oxytocin Infusion During Cesarean Delivery in 90% Population of Nonlaboring Patients With Preeclampsia Receiving Magnesium Sulfate Therapy and Normotensives: An Up-Down Sequential Allocation Dose-Response Study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29879293" id="rid54" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>55 : Prophylactic use of ergot alkaloids in the third stage of labour.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29879293" id="rid55" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>56 : Prophylactic use of ergot alkaloids in the third stage of labour.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21356004" id="rid56" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>57 : Saving Mothers' Lives: Reviewing maternal deaths to make motherhood safer: 2006-2008. The Eighth Report of the Confidential Enquiries into Maternal Deaths in the United Kingdom.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25405694" id="rid57" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>58 : Prevention of peri-induction hypertension in preeclamptic patients: a focused review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3421264" id="rid58" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>59 : The use of labetalol for attenuation of the hypertensive response to endotracheal intubation in preeclampsia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15321570" id="rid59" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>60 : Haemodynamic responses to laryngoscopy and intubation in patients with pregnancy-induced hypertension: effect of intravenous esmolol with or without lidocaine.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3927785" id="rid60" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>61 : The use of nitroglycerin in preventing the hypertensive response to tracheal intubation in severe preeclampsia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25729662" id="rid61" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>62 : Attenuation of the pressor response to tracheal intubation in severe preeclampsia: relative efficacies of nitroglycerine infusion, sublingual nifedipine, and intravenous hydralazine.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16978041" id="rid62" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>63 : Intravenous nicardipine: its use in the short-term treatment of hypertension and various other indications.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22724620" id="rid63" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>64 : Maternal and foetal effects of remifentanil for general anaesthesia in parturients undergoing caesarean section: a systematic review and meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31230994" id="rid64" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>65 : Induction opioids for caesarean section under general anaesthesia: a systematic review and meta-analysis of randomised controlled trials.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2123395" id="rid65" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>66 : Effects of alfentanil and fentanyl on induction of anaesthesia in patients with severe pregnancy-induced hypertension.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19919585" id="rid66" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>67 : Time course of rocuronium-induced neuromuscular block after pre-treatment with magnesium sulphate: a randomised study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12560310" id="rid67" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>68 : Magnesium potentiates neuromuscular blockade with cisatracurium during cardiac surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7734259" id="rid68" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>69 : Interaction of magnesium sulphate with vecuronium-induced neuromuscular block.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28885417" id="rid69" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>70 : Association of Nonsteroidal Antiinflammatory Drugs and Postpartum Hypertension in Women With Preeclampsia With Severe Features.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31764732" id="rid70" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>71 : Ibuprofen and Postpartum Blood Pressure in Women With Hypertensive Disorders of Pregnancy: A Randomized Controlled Trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29505772" id="rid71" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>72 : Effect of ibuprofen vs acetaminophen on postpartum hypertension in preeclampsia with severe features: a double-masked, randomized controlled trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28731975" id="rid72" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>73 : The Consensus Bundle on Hypertension in Pregnancy and the Anesthesiologist: Doing All the Right Things for All the Patients All of the Time.</p>
</a>
</div>
</div>
</div>
</div>
</section>
</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->
<!-- End Footer Area -->
<!-- Back to top -->
<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->
<!-- Prpper JS -->
<!-- Bootstrap Min JS -->
<!-- Classy Nav Min Js -->
<!-- Owl Carousel Min Js -->
<!-- Magnific Popup JS -->
<!-- CounterUp JS -->
<!-- Waypoints JS -->
<!-- Form Validator Min JS -->
<!-- Contact Form Min JS -->
<!-- Main JS -->
<!-- Global site tag (gtag.js) - Google Analytics -->
</body>
</html>
